Product Information
NIZATIDINE 300 MG CAPSULE is a generic product labeled by Actavis Pharma, Inc., priced at $0.7988 per EA under NDC 00591313830. Its NADAC has been published 409 times since Nov 28, 2013.
FDA first approved this application on Jul 9, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591313830
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
NIZATIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA075616FDA Approved
7/9/2002
TE Code
AB
On Market Since
7/9/2002
Pharmacological Classes
Price Statistics
The NADAC for NIZATIDINE 300 MG CAPSULE has been published 409 times since Nov 28, 2013, and over the history we have for it it has risen 30.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7988 per EA |
|---|---|
| All-time high | $0.7988 (Aug 19, 2026) |
| All-time low | $0.4171 (Mar 20, 2019) |
| 52-week high | $0.7988 |
| 52-week low | $0.7782 |
| Median price | $0.5533 |
| Average price | $0.5630 |
| Largest weekly change | +72.7% (Nov 19, 2025) |
| Weeks tracked | 409 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 27% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NIZATIDINE 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for NIZATIDINE 300 MG CAPSULE, manufactured by Actavis Pharma, Inc., is $0.7988 per EA (NDC 00591313830), effective Aug 19, 2026.
How has the price of NIZATIDINE 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for NIZATIDINE 300 MG CAPSULE has risen 30.1%. It has been tracked across 409 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NIZATIDINE 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for NIZATIDINE 300 MG CAPSULE has ranged from a low of $0.4171 (Mar 20, 2019) to a high of $0.7988 (Aug 19, 2026), with a median of $0.5533 per EA.
Are there cheaper alternatives to NIZATIDINE 300 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NIZATIDINE 300 MG CAPSULE, is $0.5821 per EA — about 27% below NIZATIDINE 300 MG CAPSULE.
Who manufactures NIZATIDINE 300 MG CAPSULE?
NIZATIDINE 300 MG CAPSULE (NDC 00591313830) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.